Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The first 25 patients.

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on May 22, 2023 6:26pm

190 Views

Post# 35459434

RE:RE:RE:RE:The first 25 patients.

One last thought on that skys1, it could just be that the data has to be presented in a certain format that satifies the FDAs requirement to grant us both BTD and AA, and tlt needed to dot all the EYES, AND they figured lets get it right since we all know there has been communication along the way with FDA, i do believe we are real close,IMO. Bought more on the drops

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement